• <em>In Vitro</em> Filaricidal Properties of Aqueous Extracts of <em>Combretum nigricans</em> (Combretaceae) on <em>Onchocerca ochengi</em> (Onchocercidae)
• A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti-Wolbachia Candidate Macrofilaricide
• A review of epidemiology of lymphatic filariasis in Nigeria
• Accelerating onchocerciasis elimination in humanitarian settings: lessons from South Sudan
• Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?
• Active infection with Onchocerca volvulus and the linkage to epilepsy/nodding syndrome
• An Updated Economic Assessment of Moxidectin Treatment Strategies for Onchocerciasis Elimination
• Assessment of community knowledge and participation in onchocerciasis programme, challenges in ivermectin drug delivery, distribution and non-compliance in Ogun State, southwest Nigeria
• Association between arterial stiffness and Loa loa microfilaremia in a rural area of the Republic of Congo: A population-based cross-sectional study (the MorLo project)
• Association of haemato-biochemical indices and blood composite ratios with microfilaridermia in Onchocerciasis patients
• Changes in Anti-OV-16 IgG4 Responses to Onchocerciasis after Elimination of Transmission in the Central Endemic Zone of Guatemala
• Characterization by MALDI-TOF MS and 16S rRNA Gene Sequencing of Aerobic Endospore-Forming Bacteria Isolated from Pharmaceutical Facility in Rio de Janeiro, Brazil
• Chorioretinitis among Immigrant and Travellers. Comment on Mansour et al. Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East. Diagnostics 2023, 13, 3626
• Combinations of the azaquinazoline anti-<em>Wolbachia</em> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasis
• Community Involvement in Onchocerciasis Post-elimination Surveillance in Bududa District, Eastern Uganda: A cross-sectional study
• Community Perceptions of Blackfly Nuisance and Acceptability of the "Slash and Clear" Vector Control Approach in the Ntui Health District of Cameroon: A Qualitative Study
• Community-Directed Vector Control to Accelerate Onchocerciasis Elimination
• Community's knowledge, perceptions and preventive practices on Onchocerciasis in Jimma zone, Ethiopia, formative mixed study
• Control, elimination, and eradication efforts for neglected tropical diseases in the World Health Organization African region over the last 30 years - A scoping review
• Control, elimination, and eradication efforts for neglected tropical diseases in the World Health Organization African region over the last 30 years: A scoping review
• Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon
• Cytotaxonomic characterization and estimation of migration patterns of onchocerciasis vectors (Simulium damnosum sensu lato) in northwestern Ethiopia based on RADSeq data
• Dementia Prevalence and <em>Onchocerca volvulus</em> Infection among Rural Elderly Persons in the Ntui Health District, Cameroon: A Population-Based Study
• Development and validation of ivermectin quantification method in volumetric absorptive microsampling using liquid chromatography-tandem mass spectrometry
• Differential susceptibility of Onchocerca ochengi adult male worms to flubendazole in gerbils and hamsters
• Do Residents Believe that Onchocerciasis Transmission Was Eliminated? Results of A Post-Treatment Surveillance Knowledge, Attitude, and Practices Survey in Three Foci of Uganda
• Doxycycline, a role in the treatment of onchocerciasis-associated epilepsy?
• Effectiveness of one and two doses of ivermectin mass drug administration in reducing the prevalence and intensity of soil-transmitted helminth (STH) infections in Western Province, Solomon Islands: a cluster-randomised, before-after analysis
• Efficacy and safety of emodepside compared with albendazole in adolescents and adults with hookworm infection in Pemba Island, Tanzania: a double-blind, superiority, phase 2b, randomised controlled trial
• Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis
• Ending lymphatic filariasis and onchocerciasis in Africa: Reasons for hope
• Equivocal diagnostics: Making a 'good' point-of-care test for elimination in global health
• Evaluating epilepsy management in an onchocerciasis-endemic area: Case of Maridi, South Sudan
• Evaluating the Potency of Selected Antibiotic Medications Dispensed in Community Pharmacies in Gwale, Kano, Nigeria
• Evaluation of genotoxic effect via expression of DNA damage responsive gene induced by ivermectin on MDBK cell line
• Exposure of Male Farmers and Nonfarmers to Neonicotinoid Pesticides in the South-West and Littoral Regions of Cameroon: A Comparative Study
• Factors Associated With Coverage in Community-directed Treatment With Ivermectin for Onchocerciasis Control in Savanah and Forest Areas in Central African Republic : A Cross- sectional Study
• Field sensitivity and specificity of the SD BIOLINE onchocerciasis IgG4 Rapid Diagnostic Test in children <10 years old from endemic areas in Burkina Faso
• Filarial disease in the Brazilian Amazon and emerging opportunities for treatment and control
• Genome-based tools for onchocerciasis elimination: utility of the mitochondrial genome for delineating Onchocerca volvulus transmission zones
• Global stability analysis and modelling onchocerciasis transmission dynamics with control measures
• GONE to combat onchocerciasis
• Helminthiasis
• Identification and characterisation of Mansonella perstans in the Volta Region of Ghana
• Identification and Characterization of Onchocerca volvulus Heat Shock Protein 70 (OvHSP70) as Novel Diagnostic Marker of Onchocerciasis in Human Urine
• Immune Reactions of Vector Insects to Parasites and Pathogens
• Impact assessment of onchocerciasis through lymphatic filariasis transmission assessment surveys using Ov-16 rapid diagnostic tests in Sierra Leone
• Impact of annual community-directed treatment with ivermectin on the incidence of epilepsy in Mvolo, a two-year prospective study
• Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators
• Impact of repeated mass ivermectin administration using a community directed approach on <em>L</em>. <em>loa</em> infection in <em>Chrysops silacea</em> of the rain forest and forest savanna of Cameroon
• Integrated Serosurveillance for Onchocerciasis, Lymphatic Filariasis, and Schistosomiasis in North Darfur, Sudan
• Integration of onchocerciasis morbidity management and disability prevention services in the healthcare system in Tanzania: a call for action and recommendations
• MAPPING, ASSOCIATED FACTORS AND PATHOPHYSIOLOGY OF NODDING SYNDROME IN AFRICA: A SYSTEMATIC REVIEW
• Mapping, Associated Factors, and Pathophysiology of Nodding Syndrome in Africa: A Systematic Review
• Mental health, stigma and the quality of life of people affected by neglected tropical diseases of the skin in Kasai Province, Democratic Republic of the Congo: a sex-disaggregated analysis
• Methodological challenges for conducting case-control studies to investigate the association between onchocerciasis and epilepsy including nodding syndrome
• Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence
• Mvolo County, an Onchocerciasis Endemic Area in Western Equatoria State, South Sudan: An Entomological Study to Prepare for a "Slash and Clear" Community-Based Vector Control Intervention
• Nodding syndrome associated with onchocerciasis
• NODDING SYNDROME: A SYSTEMATIC REVIEW
• Non-adherence to ivermectin in onchocerciasis-endemic communities with persistent infection in the Bono Region of Ghana: a mixed-methods study
• Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Gha
• Onchocerciasis
• Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against Onchocerca gutturosa in Gambia
• Onchocerciasis elimination in sub-Saharan Africa requires alternative strategies
• Onchocerciasis in the Cameroon-Chad border area after more than 20 years of annual mass ivermectin distribution
• Onchocerciasis-associated epilepsy and biomarkers
• Onchocerciasis-associated epilepsy: an explorative case-control study with viral metagenomic analyses on Onchocerca volvulus
• Onchocerciasis-associated epilepsy: Charting a path forward
• Optimized strategy for real-time qPCR detection of Onchocerca volvulus DNA in pooled Simulium sp. blackfly vectors
• Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East
• Progress Toward Onchocerciasis Elimination in Brazil
• Progress towards elimination of onchocerciasis in the Region du Sud-Ouest of Burkina Faso which was previously subject to a recrudescence event after vector control
• Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis
• Rapid diagnostic testing for onchocerciasis in Maridi (South Sudan) before and after improving elimination strategies: a repeated cross-sectional survey
• Reflecting on Decades of Data: The Global Burden of Disease-Cochrane Project
• Reply to Otiti-Sengeri et al. Chorioretinitis among Immigrant and Travellers. Comment on "Mansour et al. Presumed Onchocerciasis Chorioretinitis Spilling over into North America, Europe and Middle East. Diagnostics 2023, 13, 3626"
• Repurposed Drugs That Activate Autophagy in Filarial Worms Act as Effective Macrofilaricides
• Response to 'Nodding syndrome associated with onchocerciasis'
• Response to "Nodding Syndrome Associated with Onchocerciasis"
• Response to: 'Methodological challenges for conducting case control studies to investigate the association between onchocerciasis and epilepsy including nodding syndrome'
• Review of epilepsy care in the Democratic Republic of the Congo
• Revisiting the antigen markers of vector-borne parasitic diseases identified by immunomics: identification and application to disease control
• Robust epidemiological evidence supports the association between nodding syndrome and epilepsy
• Safety and Short-term Efficacy of a Single Dose of 2 mg Moxidectin in <em>Loa loa</em>-Infected Individuals: A Double-Blind, Randomized Ivermectin-Controlled Trial With Ascending Microfilarial Densities
• Scorecard Approach to Eliminate Onchocerciasis in Venezuela
• Significant reduction of blackfly densities in persistent onchocerciasis area following pilot implementation of an environment friendly approach (Slash and Clear)
• Suramin, an antiparasitic drug, stimulates adipocyte differentiation and promotes adipogenesis
• Synthesis of findings from the literature and a qualitative research study on the impacts of gender, disability, and ethnicity in Neglected Tropical Diseases programs
• Synthesizing environmental, epidemiological and vector and parasite genetic data to assist decision making for disease elimination
• Targeting a microbiota <em>Wolbachian</em> aminoacyl-tRNA synthetase to block its pathogenic host
• The Biodiversity of Blackflies (Diptera: Simuliidae) in Brazil: New Distribution Records and Updated Checklist
• The current status of neglected tropical diseases in Japan: A scoping review
• The effects of selected neglected tropical diseases on economic performance at the macrolevel in Africa
• The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis
• The psychosocial impacts of skin-neglected tropical diseases (SNTDs) as perceived by the affected persons: A systematic review
• The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactation
• Treatment and prevention of epilepsy in onchocerciasis-endemic areas is urgently needed
• Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment
• Virtual screening, MMGBSA, and molecular dynamics approaches for identification of natural products from South African biodiversity as potential <em>Onchocerca volvulus</em> pi-class glutathione S-transferase inhibitors